Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Income from Non-Controlling Interests (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Income from Non-Controlling Interests for 8 consecutive years, with $18.1 million as the latest value for Q1 2025.

  • On a quarterly basis, Income from Non-Controlling Interests fell 10.95% to $18.1 million in Q1 2025 year-over-year; TTM through Mar 2025 was $80.9 million, a 35.69% increase, with the full-year FY2023 number at $56.2 million, up 44.09% from a year prior.
  • Income from Non-Controlling Interests was $18.1 million for Q1 2025 at Select Medical Holdings, down from $25.4 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $31.3 million in Q2 2021 to a low of $6.8 million in Q1 2022.
  • A 5-year average of $17.6 million and a median of $16.8 million in 2021 define the central range for Income from Non-Controlling Interests.
  • Peak YoY movement for Income from Non-Controlling Interests: soared 97.74% in 2021, then tumbled 74.47% in 2022.
  • Select Medical Holdings' Income from Non-Controlling Interests stood at $16.5 million in 2021, then tumbled by 37.96% to $10.2 million in 2022, then surged by 52.13% to $15.5 million in 2023, then skyrocketed by 63.48% to $25.4 million in 2024, then dropped by 28.9% to $18.1 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Income from Non-Controlling Interests are $18.1 million (Q1 2025), $25.4 million (Q3 2024), and $17.2 million (Q2 2024).